nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—JUN—Cellular responses to stress—E2F1—ocular cancer	0.000988	0.000988	CbGpPWpGaD
Irbesartan—JUN—TCR Signaling Pathway—TGFB1—ocular cancer	0.000984	0.000984	CbGpPWpGaD
Irbesartan—JUN—BCR signaling pathway—HRAS—ocular cancer	0.000981	0.000981	CbGpPWpGaD
Irbesartan—JUN—Signaling by NOTCH—EP300—ocular cancer	0.000971	0.000971	CbGpPWpGaD
Irbesartan—JUN—CDC42 signaling events—HRAS—ocular cancer	0.000947	0.000947	CbGpPWpGaD
Irbesartan—JUN—Fc-epsilon receptor I signaling in mast cells—AKT1—ocular cancer	0.000934	0.000934	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—MDM2—ocular cancer	0.000933	0.000933	CbGpPWpGaD
Irbesartan—JUN—B Cell Receptor Signaling Pathway—MYC—ocular cancer	0.000929	0.000929	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—RB1—ocular cancer	0.000927	0.000927	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—GNA11—ocular cancer	0.000918	0.000918	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—E2F5—ocular cancer	0.000917	0.000917	CbGpPWpGaD
Irbesartan—JUN—Endothelins—AKT1—ocular cancer	0.00091	0.00091	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—CCND1—ocular cancer	0.000905	0.000905	CbGpPWpGaD
Irbesartan—JUN—LPA receptor mediated events—AKT1—ocular cancer	0.000899	0.000899	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—E2F4—ocular cancer	0.000899	0.000899	CbGpPWpGaD
Irbesartan—JUN—Wnt Signaling Pathway and Pluripotency—MYC—ocular cancer	0.000893	0.000893	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—RB1—ocular cancer	0.000889	0.000889	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—RBL1—ocular cancer	0.000881	0.000881	CbGpPWpGaD
Irbesartan—JUN—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000877	0.000877	CbGpPWpGaD
Irbesartan—JUN—AGE/RAGE pathway—AKT1—ocular cancer	0.000877	0.000877	CbGpPWpGaD
Irbesartan—JUN—TSH signaling pathway—AKT1—ocular cancer	0.000877	0.000877	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—CDKN1A—ocular cancer	0.000876	0.000876	CbGpPWpGaD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—TP53—ocular cancer	0.000873	0.000873	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—TGFB1—ocular cancer	0.00087	0.00087	CbGpPWpGaD
Irbesartan—JUN—BCR signaling pathway—AKT1—ocular cancer	0.000866	0.000866	CbGpPWpGaD
Irbesartan—JUN—Apoptosis—TP53—ocular cancer	0.000856	0.000856	CbGpPWpGaD
Irbesartan—JUN—Regulation of Telomerase—AKT1—ocular cancer	0.000856	0.000856	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—GNAQ—ocular cancer	0.000853	0.000853	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—CDK2—ocular cancer	0.000852	0.000852	CbGpPWpGaD
Irbesartan—JUN—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—ocular cancer	0.000851	0.000851	CbGpPWpGaD
Irbesartan—JUN—Signaling by NOTCH—MYC—ocular cancer	0.000846	0.000846	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—MYC—ocular cancer	0.000846	0.000846	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—TGFB1—ocular cancer	0.000844	0.000844	CbGpPWpGaD
Irbesartan—JUN—Direct p53 effectors—CDKN1A—ocular cancer	0.000836	0.000836	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—GNA11—ocular cancer	0.000833	0.000833	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—EP300—ocular cancer	0.000833	0.000833	CbGpPWpGaD
Irbesartan—UGT1A3—NRF2 pathway—TGFB1—ocular cancer	0.000828	0.000828	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—MDM2—ocular cancer	0.000822	0.000822	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—SAG—ocular cancer	0.000813	0.000813	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—CCND1—ocular cancer	0.000813	0.000813	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—CDK4—ocular cancer	0.000805	0.000805	CbGpPWpGaD
Irbesartan—JUN—Apoptosis Modulation and Signaling—TP53—ocular cancer	0.000803	0.000803	CbGpPWpGaD
Irbesartan—JUN—Direct p53 effectors—EP300—ocular cancer	0.000795	0.000795	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—MDM2—ocular cancer	0.00079	0.00079	CbGpPWpGaD
Irbesartan—JUN—TCR Signaling Pathway—HRAS—ocular cancer	0.000775	0.000775	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—GNAQ—ocular cancer	0.000775	0.000775	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000773	0.000773	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PSPH—ocular cancer	0.000766	0.000766	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—E2F3—ocular cancer	0.000764	0.000764	CbGpPWpGaD
Irbesartan—JUN—TNF alpha Signaling Pathway—HRAS—ocular cancer	0.000761	0.000761	CbGpPWpGaD
Irbesartan—JUN—PDGFR-beta signaling pathway—MYC—ocular cancer	0.000759	0.000759	CbGpPWpGaD
Irbesartan—CYP1A2—Tryptophan metabolism—MDM2—ocular cancer	0.000758	0.000758	CbGpPWpGaD
Irbesartan—JUN—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—AKT1—ocular cancer	0.000752	0.000752	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—CDKN1B—ocular cancer	0.000751	0.000751	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—EP300—ocular cancer	0.000748	0.000748	CbGpPWpGaD
Irbesartan—JUN—Regulation of nuclear SMAD2/3 signaling—AKT1—ocular cancer	0.000744	0.000744	CbGpPWpGaD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—AKT1—ocular cancer	0.000737	0.000737	CbGpPWpGaD
Irbesartan—JUN—Wnt Signaling Pathway and Pluripotency—TP53—ocular cancer	0.000733	0.000733	CbGpPWpGaD
Irbesartan—JUN—B Cell Receptor Signaling Pathway—HRAS—ocular cancer	0.00073	0.00073	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—EP300—ocular cancer	0.000729	0.000729	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—MYC—ocular cancer	0.000726	0.000726	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—TGFB1—ocular cancer	0.000724	0.000724	CbGpPWpGaD
Irbesartan—JUN—Apoptosis—AKT1—ocular cancer	0.000723	0.000723	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—CDKN1B—ocular cancer	0.000721	0.000721	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—GNA11—ocular cancer	0.00072	0.00072	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—E2F5—ocular cancer	0.00072	0.00072	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—TP53—ocular cancer	0.000716	0.000716	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TFDP1—ocular cancer	0.00071	0.00071	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000706	0.000706	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—E2F4—ocular cancer	0.000705	0.000705	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—RB1—ocular cancer	0.0007	0.0007	CbGpPWpGaD
Irbesartan—JUN—Signaling by NOTCH—TP53—ocular cancer	0.000695	0.000695	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—TP53—ocular cancer	0.000695	0.000695	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—CDKN1A—ocular cancer	0.000693	0.000693	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.000692	0.000692	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	0.000692	0.000692	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—RBL1—ocular cancer	0.000691	0.000691	CbGpPWpGaD
Irbesartan—JUN—Androgen receptor signaling pathway—AKT1—ocular cancer	0.00069	0.00069	CbGpPWpGaD
Irbesartan—JUN—ErbB1 downstream signaling—HRAS—ocular cancer	0.000685	0.000685	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—HRAS—ocular cancer	0.000685	0.000685	CbGpPWpGaD
Irbesartan—JUN—TCR Signaling Pathway—AKT1—ocular cancer	0.000684	0.000684	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—CCND1—ocular cancer	0.000677	0.000677	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000674	0.000674	CbGpPWpGaD
Irbesartan—JUN—TNF alpha Signaling Pathway—AKT1—ocular cancer	0.000672	0.000672	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—GNAQ—ocular cancer	0.00067	0.00067	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—CDKN1A—ocular cancer	0.000666	0.000666	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—HRAS—ocular cancer	0.000665	0.000665	CbGpPWpGaD
Irbesartan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.000659	0.000659	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—GNA11—ocular cancer	0.000654	0.000654	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.000652	0.000652	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000652	0.000652	CbGpPWpGaD
Irbesartan—JUN—Oxidative Stress Induced Senescence—TP53—ocular cancer	0.000648	0.000648	CbGpPWpGaD
Irbesartan—JUN—B Cell Receptor Signaling Pathway—AKT1—ocular cancer	0.000644	0.000644	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.000638	0.000638	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.00062	0.00062	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—AKT1—ocular cancer	0.000619	0.000619	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—GNAQ—ocular cancer	0.000608	0.000608	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SAG—ocular cancer	0.000608	0.000608	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	0.000607	0.000607	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.000607	0.000607	CbGpPWpGaD
Irbesartan—JUN—ErbB1 downstream signaling—AKT1—ocular cancer	0.000605	0.000605	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—E2F3—ocular cancer	0.0006	0.0006	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—MYC—ocular cancer	0.000599	0.000599	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—TGFB1—ocular cancer	0.000597	0.000597	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—MDM2—ocular cancer	0.000597	0.000597	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—TP53—ocular cancer	0.000596	0.000596	CbGpPWpGaD
Irbesartan—JUN—PDGFR-beta signaling pathway—HRAS—ocular cancer	0.000596	0.000596	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—EP300—ocular cancer	0.000595	0.000595	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—AKT1—ocular cancer	0.000587	0.000587	CbGpPWpGaD
Irbesartan—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.000585	0.000585	CbGpPWpGaD
Irbesartan—JUN—Direct p53 effectors—TP53—ocular cancer	0.000569	0.000569	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MAML2—ocular cancer	0.000564	0.000564	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TFDP1—ocular cancer	0.000557	0.000557	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—CDKN1B—ocular cancer	0.000545	0.000545	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.00054	0.00054	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000539	0.000539	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—E2F5—ocular cancer	0.000538	0.000538	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.000536	0.000536	CbGpPWpGaD
Irbesartan—JUN—BDNF signaling pathway—HRAS—ocular cancer	0.000532	0.000532	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.000529	0.000529	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.000528	0.000528	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—E2F4—ocular cancer	0.000527	0.000527	CbGpPWpGaD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.000517	0.000517	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—RBL1—ocular cancer	0.000517	0.000517	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—AKT1—ocular cancer	0.000504	0.000504	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—CDKN1A—ocular cancer	0.000503	0.000503	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PSPH—ocular cancer	0.000495	0.000495	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—GNA11—ocular cancer	0.000492	0.000492	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—TP53—ocular cancer	0.000492	0.000492	CbGpPWpGaD
Irbesartan—JUN—Insulin Signaling—HRAS—ocular cancer	0.000489	0.000489	CbGpPWpGaD
Irbesartan—JUN—EGF/EGFR Signaling Pathway—HRAS—ocular cancer	0.000484	0.000484	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—AKT1—ocular cancer	0.000483	0.000483	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—EP300—ocular cancer	0.000479	0.000479	CbGpPWpGaD
Irbesartan—JUN—BDNF signaling pathway—AKT1—ocular cancer	0.00047	0.00047	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—GNAQ—ocular cancer	0.000458	0.000458	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—TP53—ocular cancer	0.000453	0.000453	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.000452	0.000452	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—HRAS—ocular cancer	0.000451	0.000451	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—E2F3—ocular cancer	0.000448	0.000448	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000444	0.000444	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MAML2—ocular cancer	0.000443	0.000443	CbGpPWpGaD
Irbesartan—JUN—Insulin Signaling—AKT1—ocular cancer	0.000432	0.000432	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GNA11—ocular cancer	0.000428	0.000428	CbGpPWpGaD
Irbesartan—JUN—EGF/EGFR Signaling Pathway—AKT1—ocular cancer	0.000428	0.000428	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—HRAS—ocular cancer	0.000426	0.000426	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—TP53—ocular cancer	0.000426	0.000426	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TFDP1—ocular cancer	0.000416	0.000416	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.000416	0.000416	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—AKT1—ocular cancer	0.000415	0.000415	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—HDAC1—ocular cancer	0.000413	0.000413	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PSPH—ocular cancer	0.000406	0.000406	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PSPH—ocular cancer	0.000403	0.000403	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—AKT1—ocular cancer	0.000398	0.000398	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GNAQ—ocular cancer	0.000398	0.000398	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—GNA11—ocular cancer	0.000386	0.000386	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—AKT1—ocular cancer	0.000376	0.000376	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000375	0.000375	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CDKN2B—ocular cancer	0.00037	0.00037	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—GNAQ—ocular cancer	0.000359	0.000359	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PSPH—ocular cancer	0.000344	0.000344	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—TP53—ocular cancer	0.000343	0.000343	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—E2F1—ocular cancer	0.000339	0.000339	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MAML2—ocular cancer	0.000331	0.000331	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HDAC1—ocular cancer	0.000324	0.000324	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—MDM2—ocular cancer	0.000319	0.000319	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CDKN1B—ocular cancer	0.000292	0.000292	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CDKN2B—ocular cancer	0.00029	0.00029	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—GNA11—ocular cancer	0.000289	0.000289	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CDKN1A—ocular cancer	0.000269	0.000269	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—GNAQ—ocular cancer	0.000268	0.000268	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—E2F1—ocular cancer	0.000266	0.000266	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PSPH—ocular cancer	0.000265	0.000265	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—EP300—ocular cancer	0.000256	0.000256	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HDAC1—ocular cancer	0.000242	0.000242	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GNA11—ocular cancer	0.000241	0.000241	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GNAQ—ocular cancer	0.000224	0.000224	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CDKN2B—ocular cancer	0.000217	0.000217	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MDM2—ocular cancer	0.000205	0.000205	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—E2F1—ocular cancer	0.000199	0.000199	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—HRAS—ocular cancer	0.000191	0.000191	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CDKN1B—ocular cancer	0.000187	0.000187	CbGpPWpGaD
Irbesartan—JUN—Immune System—MDM2—ocular cancer	0.000186	0.000186	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—AKT1—ocular cancer	0.000185	0.000185	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000181	0.000181	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CCND1—ocular cancer	0.000179	0.000179	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—HRAS—ocular cancer	0.000175	0.000175	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CDKN1A—ocular cancer	0.000173	0.000173	CbGpPWpGaD
Irbesartan—JUN—Immune System—CDKN1B—ocular cancer	0.00017	0.00017	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—AKT1—ocular cancer	0.000168	0.000168	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—EP300—ocular cancer	0.000164	0.000164	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MDM2—ocular cancer	0.000161	0.000161	CbGpPWpGaD
Irbesartan—JUN—Immune System—CDKN1A—ocular cancer	0.000157	0.000157	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GNA11—ocular cancer	0.000156	0.000156	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—AKT1—ocular cancer	0.000155	0.000155	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—HRAS—ocular cancer	0.00015	0.00015	CbGpPWpGaD
Irbesartan—JUN—Immune System—EP300—ocular cancer	0.000149	0.000149	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CDKN1B—ocular cancer	0.000147	0.000147	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—AKT1—ocular cancer	0.000145	0.000145	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GNAQ—ocular cancer	0.000145	0.000145	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MYC—ocular cancer	0.000143	0.000143	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TGFB1—ocular cancer	0.000143	0.000143	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—EP300—ocular cancer	0.000143	0.000143	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCND1—ocular cancer	0.00014	0.00014	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CDKN1A—ocular cancer	0.000136	0.000136	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—AKT1—ocular cancer	0.000132	0.000132	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—EP300—ocular cancer	0.000129	0.000129	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GNA11—ocular cancer	0.000128	0.000128	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GNA11—ocular cancer	0.000127	0.000127	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MDM2—ocular cancer	0.00012	0.00012	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GNAQ—ocular cancer	0.000119	0.000119	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GNAQ—ocular cancer	0.000118	0.000118	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TP53—ocular cancer	0.000118	0.000118	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000117	0.000117	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—HRAS—ocular cancer	0.000113	0.000113	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MYC—ocular cancer	0.000112	0.000112	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TGFB1—ocular cancer	0.000112	0.000112	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CDKN1B—ocular cancer	0.00011	0.00011	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GNA11—ocular cancer	0.000108	0.000108	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCND1—ocular cancer	0.000105	0.000105	CbGpPWpGaD
Irbesartan—JUN—Immune System—HRAS—ocular cancer	0.000102	0.000102	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CDKN1A—ocular cancer	0.000101	0.000101	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GNAQ—ocular cancer	0.000101	0.000101	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—AKT1—ocular cancer	9.94e-05	9.94e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—EP300—ocular cancer	9.64e-05	9.64e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	9.5e-05	9.5e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TP53—ocular cancer	9.24e-05	9.24e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—AKT1—ocular cancer	9.01e-05	9.01e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HRAS—ocular cancer	8.83e-05	8.83e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—AKT1—ocular cancer	8.64e-05	8.64e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MYC—ocular cancer	8.4e-05	8.4e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TGFB1—ocular cancer	8.38e-05	8.38e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GNA11—ocular cancer	8.35e-05	8.35e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	8.12e-05	8.12e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—EP300—ocular cancer	8.05e-05	8.05e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—AKT1—ocular cancer	7.8e-05	7.8e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GNAQ—ocular cancer	7.77e-05	7.77e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TP53—ocular cancer	6.9e-05	6.9e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HRAS—ocular cancer	6.6e-05	6.6e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—AKT1—ocular cancer	5.83e-05	5.83e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—EP300—ocular cancer	5.2e-05	5.2e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—AKT1—ocular cancer	4.87e-05	4.87e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—EP300—ocular cancer	4.27e-05	4.27e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—EP300—ocular cancer	4.23e-05	4.23e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—EP300—ocular cancer	3.62e-05	3.62e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—AKT1—ocular cancer	3.14e-05	3.14e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—EP300—ocular cancer	2.79e-05	2.79e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—AKT1—ocular cancer	2.58e-05	2.58e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—AKT1—ocular cancer	2.56e-05	2.56e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—AKT1—ocular cancer	2.19e-05	2.19e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—AKT1—ocular cancer	1.69e-05	1.69e-05	CbGpPWpGaD
